- Home
- Publications
- Publication Search
- Publication Details
Title
Complementing the Cancer-Immunity Cycle
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-12
DOI
10.3389/fimmu.2019.00774
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects
- (2018) Daniel Ajona et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Complement and the Regulation of T Cell Responses
- (2018) Erin E. West et al. Annual Review of Immunology
- Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression
- (2018) Jian Chen et al. CANCER LETTERS
- CD10 + GPR77 + Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
- (2018) Shicheng Su et al. CELL
- Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer
- (2018) Chunmei Piao et al. EXPERIMENTAL CELL RESEARCH
- C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation
- (2018) Chenhui Zhao et al. ONCOGENE
- C1q restrains autoimmunity and viral infection by regulating CD8+T cell metabolism
- (2018) Guang Sheng Ling et al. SCIENCE
- Lymphocyte integration of complement cues
- (2018) Ana V. Marin et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Targeting complement-mediated immunoregulation for cancer immunotherapy
- (2018) Martin Kolev et al. SEMINARS IN IMMUNOLOGY
- Complementing Cancer Metastasis
- (2018) Dawn M. Kochanek et al. Frontiers in Immunology
- Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
- (2018) Kristina Buder-Bakhaya et al. Frontiers in Immunology
- Complement as a Biological Tool to Control Tumor Growth
- (2018) Paolo Macor et al. Frontiers in Immunology
- Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
- (2018) Christopher Groth et al. BRITISH JOURNAL OF CANCER
- Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy
- (2018) Terry R. Medler et al. CANCER CELL
- Complement C5a-Mediated TAM-ing of Antitumor Immunity Drives Squamous Carcinogenesis
- (2018) Dimitrios C. Mastellos et al. CANCER CELL
- A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
- (2018) Livnat Jerby-Arnon et al. CELL
- Mouse Models for Cancer Immunotherapy Research
- (2018) Brian Olson et al. Cancer Discovery
- Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages
- (2018) Haoran Zha et al. Cancer Immunology Research
- The complement system in cancer: Ambivalence between tumour destruction and promotion
- (2017) Srinivas Mamidi et al. IMMUNOBIOLOGY
- Tumor-Derived Tissue Factor Aberrantly Activates Complement and Facilitates Lung Tumor Progression via Recruitment of Myeloid-Derived Suppressor Cells
- (2017) Xiao Han et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of the complement system in cancer
- (2017) Vahid Afshar-Kharghan JOURNAL OF CLINICAL INVESTIGATION
- The Ribosomal Protein S19 Suppresses Antitumor Immune Responses via the Complement C5a Receptor 1
- (2017) Maciej M. Markiewski et al. JOURNAL OF IMMUNOLOGY
- New concepts on the therapeutic control of complement anaphylatoxin receptors
- (2017) Owen A. Hawksworth et al. MOLECULAR IMMUNOLOGY
- Intracellular complement − the complosome − in immune cell regulation
- (2017) Giuseppina Arbore et al. MOLECULAR IMMUNOLOGY
- IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity
- (2017) Martina Molgora et al. NATURE
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines
- (2017) Jason Lohmueller et al. PHARMACOLOGY & THERAPEUTICS
- Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment
- (2017) Daniel Ajona et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis
- (2017) Daniel Ajona et al. Cancer Discovery
- PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
- (2017) Maria Gato-Cañas et al. Cell Reports
- Myeloid-Derived Suppressor Cells
- (2017) Dmitry I. Gabrilovich Cancer Immunology Research
- A Serum Protein Signature Associated with Outcome after Anti–PD-1 Therapy in Metastatic Melanoma
- (2017) Jeffrey S. Weber et al. Cancer Immunology Research
- Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockade
- (2017) Haoran Zha et al. OncoImmunology
- Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy
- (2017) Andrea Facciabene et al. OncoImmunology
- Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
- (2016) J. M. Kim et al. ANNALS OF ONCOLOGY
- Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes
- (2016) M Martin et al. CELL DEATH AND DIFFERENTIATION
- Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation
- (2016) A D Garg et al. CELL DEATH AND DIFFERENTIATION
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
- (2016) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial–mesenchymal transition
- (2016) Wen-Hao Hu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Therapeutic control of complement activation at the level of the central component C3
- (2016) Daniel Ricklin et al. IMMUNOBIOLOGY
- Innate immune mediators in cancer: between defense and resistance
- (2016) Pedro Berraondo et al. IMMUNOLOGICAL REVIEWS
- A journey through the lectin pathway of complement-MBL and beyond
- (2016) Peter Garred et al. IMMUNOLOGICAL REVIEWS
- Human NK cells: From surface receptors to clinical applications
- (2016) Lorenzo Moretta et al. IMMUNOLOGY LETTERS
- The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+T Cell Responses
- (2016) Jamileh A. Nabizadeh et al. JOURNAL OF IMMUNOLOGY
- The Complement Inhibitor Factor H Generates an Anti-Inflammatory and Tolerogenic State in Monocyte-Derived Dendritic Cells
- (2016) Rut Olivar et al. JOURNAL OF IMMUNOLOGY
- Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1
- (2016) A Abdelbaset-Ismail et al. LEUKEMIA
- T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells
- (2016) G. Arbore et al. SCIENCE
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy
- (2016) Yoshihiro Wada et al. Oncology Letters
- C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation
- (2016) Roberta Bulla et al. Nature Communications
- Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression
- (2016) Y. Wang et al. Cancer Discovery
- C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA
- (2016) Takayoshi Kaida et al. Oncotarget
- Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies
- (2016) Laura Evgin et al. Molecular Therapy-Oncolytics
- High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma
- (2016) Wei Xi et al. Scientific Reports
- Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathways
- (2016) Ling-Ling An et al. Scientific Reports
- PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
- (2015) Eduardo Bonavita et al. CELL
- Complement Is a Central Mediator of Radiotherapy-Induced Tumor-Specific Immunity and Clinical Response
- (2015) Laura Surace et al. IMMUNITY
- Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration
- (2015) Chunmei Piao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pulmonary Alveolar Macrophages Contribute to the Premetastatic Niche by Suppressing Antitumor T Cell Responses in the Lungs
- (2015) Sharad K. Sharma et al. JOURNAL OF IMMUNOLOGY
- Complement Inhibition Prevents Oncolytic Vaccinia Virus Neutralization in Immune Humans and Cynomolgus Macaques
- (2015) Laura Evgin et al. MOLECULAR THERAPY
- C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways
- (2015) YOSHIHIRO MAEDA et al. ONCOLOGY REPORTS
- Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma
- (2015) D Ajona et al. ORAL DISEASES
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Influence of the C5a–C5a receptor system on breast cancer progression and patient prognosis
- (2015) Takahisa Imamura et al. Breast Cancer
- Genetic and Pharmacologic Inhibition of Complement Impairs Endothelial Cell Function and Ablates Ovarian Cancer Neovascularization
- (2015) Selene Nunez-Cruz et al. NEOPLASIA
- Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
- (2014) S. K. Vadrevu et al. CANCER RESEARCH
- C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β-arrestin recruitment
- (2014) Daniel E Croker et al. IMMUNOLOGY AND CELL BIOLOGY
- Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation
- (2014) Elizabeth V. Clarke et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- C5a stimulates the proliferation of breast cancer cells via Akt-dependent RGC-32 gene activation
- (2014) YI LU et al. ONCOLOGY REPORTS
- Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness
- (2014) HIDETOSHI NITTA et al. ONCOLOGY REPORTS
- C5a promotes the proliferation of human nasopharyngeal carcinoma cells through PCAF-mediated STAT3 acetylation
- (2014) KEMIN CAI et al. ONCOLOGY REPORTS
- C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens
- (2014) L. Baudino et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- C1q as a unique player in angiogenesis with therapeutic implication in wound healing
- (2014) F. Bossi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autocrine Effects of Tumor-Derived Complement
- (2014) Min Soon Cho et al. Cell Reports
- Role of the complement system in NK cell-mediated antitumor T-cell responses
- (2014) Valérie Janelle et al. OncoImmunology
- The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells
- (2013) C.-C. Hsieh et al. BLOOD
- Molecular Pathways: Coexpression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy
- (2013) C. J. Nirschl et al. CLINICAL CANCER RESEARCH
- Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88)
- (2013) H. Nitta et al. CLINICAL CANCER RESEARCH
- Intracellular Complement Activation Sustains T Cell Homeostasis and Mediates Effector Differentiation
- (2013) M. Kathryn Liszewski et al. IMMUNITY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells
- (2013) Wing-hong Kwan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: Receptors for C3a and C5a Modulate Stability of Alloantigen-Reactive Induced Regulatory T Cells
- (2013) W. van der Touw et al. JOURNAL OF IMMUNOLOGY
- Complement in Immune and Inflammatory Disorders: Therapeutic Interventions
- (2013) D. Ricklin et al. JOURNAL OF IMMUNOLOGY
- Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer
- (2013) Daniel Ajona et al. JNCI-Journal of the National Cancer Institute
- Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer
- (2013) Jie Gu et al. LUNG CANCER
- Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation
- (2013) Arije Ghannam et al. MOLECULAR IMMUNOLOGY
- Complement inhibition in cancer therapy
- (2013) Ruben Pio et al. SEMINARS IN IMMUNOLOGY
- Many faces of DAMPs in cancer therapy
- (2013) O Krysko et al. Cell Death & Disease
- Transient Complement Inhibition Promotes a Tumor-Specific Immune Response through the Implication of Natural Killer Cells
- (2013) V. Janelle et al. Cancer Immunology Research
- Complement Protein C1q Directs Macrophage Polarization and Limits Inflammasome Activity during the Uptake of Apoptotic Cells
- (2012) M. E. Benoit et al. JOURNAL OF IMMUNOLOGY
- Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
- (2012) Leticia Corrales et al. JOURNAL OF IMMUNOLOGY
- Opposing Roles for Complement Component C5a in Tumor Progression and the Tumor Microenvironment
- (2012) L. Gunn et al. JOURNAL OF IMMUNOLOGY
- The CD46-Jagged1 interaction is critical for human TH1 immunity
- (2012) Gaëlle Le Friec et al. NATURE IMMUNOLOGY
- Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a
- (2011) Ke Li et al. IMMUNOBIOLOGY
- Lessons from functional and structural analyses of disease-associated genetic variants in the complement alternative pathway
- (2010) Santiago Rodríguez de Córdoba et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
- (2010) R. K. Shrimali et al. CANCER RESEARCH
- New insights into the molecular mechanisms of classical complement activation
- (2010) Mihaela Kojouharova et al. MOLECULAR IMMUNOLOGY
- Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells
- (2010) John Cardone et al. NATURE IMMUNOLOGY
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation
- (2009) Abhishek D. Garg et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- C1q enhances IFN- production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells
- (2009) P. Baruah et al. BLOOD
- Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H
- (2009) M Mihlan et al. CELL DEATH AND DIFFERENTIATION
- Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis
- (2008) P. N. Lalli et al. BLOOD
- Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T Cells
- (2008) Michael G. Strainic et al. IMMUNITY
- Multiple roles for CD4+T cells in anti-tumor immune responses
- (2008) Richard Kennedy et al. IMMUNOLOGICAL REVIEWS
- Understanding Systemic Lupus Erythematosus Physiopathology in the Light of Primary Immunodeficiencies
- (2008) Magda Carneiro-Sampaio et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
- The highway code of T cell trafficking
- (2007) FM Marelli-Berg et al. JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started